These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8696875)

  • 61. Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study.
    Klefter ON; Hommel E; Munch IC; Nørgaard K; Madsbad S; Larsen M
    Acta Ophthalmol; 2016 Sep; 94(6):540-7. PubMed ID: 27126300
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care.
    Lövestam-Adrian M; Agardh CD; Torffvit O; Agardh E
    J Diabetes Complications; 2001; 15(6):287-94. PubMed ID: 11711321
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation.
    Lövestam-Adrian M; Agardh CD; Torffvit O; Agardh E
    Acta Ophthalmol Scand; 2003 Jun; 81(3):221-5. PubMed ID: 12780397
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Retinal blood flow is increased in type 1 diabetes mellitus patients with advanced stages of retinopathy.
    Nguyen HT; van Duinkerken E; Verbraak FD; Polak BC; Ringens PJ; Diamant M; Moll AC
    BMC Endocr Disord; 2016 May; 16(1):25. PubMed ID: 27230581
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan.
    Lin CH; Huang CH; Tsai JS; Hsieh SH; Sun JH; Huang BY; Huang MJ; Huang YY
    Endocr J; 2011; 58(10):835-40. PubMed ID: 21828934
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.
    Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF
    Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study.
    Guillausseau PJ; Massin P; Charles MA; Allaguy H; Güvenli Z; Virally M; Tielmans D; Assayag M; Warnet A; Lubetzki J
    Diabet Med; 1998 Feb; 15(2):151-5. PubMed ID: 9507917
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
    Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
    Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Influence of good blood sugar control in diabetic retinopathy].
    Kohner EM
    Journ Annu Diabetol Hotel Dieu; 1984; ():327-32. PubMed ID: 6399536
    [No Abstract]   [Full Text] [Related]  

  • 72. Severity of background retinopathy in type 1 diabetes increases with the level of long-term glycated haemoglobin.
    Kullberg CE; Finnström K; Arnqvist HJ
    Acta Ophthalmol (Copenh); 1994 Apr; 72(2):181-8. PubMed ID: 8079623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insulin pumps--still a research tool?
    Lauritzen T; Pramming S
    Ann Clin Res; 1984; 16(2):98-106. PubMed ID: 6380393
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Macular recovery recorded by nyctometry in insulin-dependent diabetes mellitus.
    Frost-Larsen K
    Acta Ophthalmol Suppl (1985); 1991; (203):1-39. PubMed ID: 1667959
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term safety and efficacy of programmable implantable insulin delivery systems.
    Olsen CL; Liu G; Iravani M; Nguyen S; Khourdadjian K; Turner DS; Waxman K; Selam JL; Charles MA
    Int J Artif Organs; 1993 Dec; 16(12):847-54. PubMed ID: 8175202
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of stereofundus photographs in patients with insulin-dependent diabetes during conventional insulin treatment or continuous subcutaneous insulin infusion.
    Canny CL; Kohner EM; Trautman J; Puklin J; Morse P
    Diabetes; 1985 Aug; 34 Suppl 3():50-5. PubMed ID: 3894128
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of long-term near normal glycemic control on mild diabetic retinopathy.
    Friberg TR; Rosenstock J; Sanborn G; Vaghefi A; Raskin P
    Ophthalmology; 1985 Aug; 92(8):1051-8. PubMed ID: 4047600
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The course of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion].
    Hooymans JM; van Ballegooie E; Reitsma WD; Schweitzer NM
    Ned Tijdschr Geneeskd; 1988 Apr; 132(14):624-8. PubMed ID: 3362238
    [No Abstract]   [Full Text] [Related]  

  • 79. The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes.
    Bek T; Kjaergaard J
    Eur J Ophthalmol; 2004; 14(6):538-42. PubMed ID: 15638104
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.
    Feldt-Rasmussen B; Mathiesen ER; Deckert T
    Lancet; 1986 Dec; 2(8519):1300-4. PubMed ID: 2878175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.